Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Natural history of lung function over one year in patients with Parkinson's disease.
Journal: Respiratory medicine
Published: January 12, 2021
Pharmacokinetics of Inhaled Levodopa Administered With Oral Carbidopa in the Fed State in Patients With Parkinson's Disease.
Journal: Clinical therapeutics
Published: January 23, 2020
A 12-month, dose-level blinded safety and efficacy study of levodopa inhalation powder (CVT-301, Inbrija) in patients with Parkinson's disease.
Journal: Parkinsonism & related disorders
Published: November 08, 2019
Inhaled levodopa in Parkinson's disease patients with OFF periods: A randomized 12-month pulmonary safety study.
Journal: Parkinsonism & related disorders
Published: May 09, 2019
Activator protein-1 and caspase 8 mediate p38α MAPK-dependent cardiomyocyte apoptosis induced by palmitic acid.
Journal: Apoptosis : an international journal on programmed cell death
Published: March 18, 2019
Orally inhaled levodopa (CVT-301) for early morning OFF periods in Parkinson's disease.
Journal: Parkinsonism & related disorders
Published: December 19, 2018
Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 trial.
Journal: The Lancet. Neurology
Published: May 16, 2018
p38α mitogen-activated kinase mediates cardiomyocyte apoptosis induced by palmitate.
Journal: Biochemical and biophysical research communications
Published: May 27, 2014
Growing collateral arteries on demand.
Journal: Recent patents on cardiovascular drug discovery
Published: March 14, 2011
Showing 1-9 of 9
Last Updated: 09/26/2026